All Stories

  1. Detection of p53 mutations in proliferating vascular cells in glioblastoma multiforme

    Article • Journal of Neurosurgery, February 2015, Journal of Neurosurgery Publishing Group (JNSPG)

    Tsuyoshi Fukushima

  2. Inhibition of nuclear factor-κB signaling suppresses Spint-1-deletion-induced tumor susceptibility in the ApcMin/+ model

    Article • Oncotarget, November 2014, Impact Journals, LLC

    Tsuyoshi Fukushima

  3. Posterior mediastinal ganglioneuroma with peripheral replacement by white and brown adipocytes resulting in diagnostic fallacy from a false-positive 18F-2-fluoro-2-deoxyglucose-positron emission tomography finding: a case report

    Article • Journal of Medical Case Reports, October 2014, Springer Science + Business Media

    Tsuyoshi Fukushima

  4. Abstract LB-4: Ghrelin administration suppresses inflammation-associated colorectal carcinogenesis in mice

    Article • Cancer Research, September 2014, American Association for Cancer Research (AACR)

    Dr HIROAKI KATAOKA, Tsuyoshi Fukushima

  5. Abstract 4859: Hepatocyte growth factor activator inhibitor type 1 suppresses invasion of pancreatic adenocarcinoma cells through inhibition of matriptase/protease-activated receptor-2 axis

    Article • Cancer Research, September 2014, American Association for Cancer Research (AACR)

    Dr HIROAKI KATAOKA, Tsuyoshi Fukushima

  6. Abstract B24: Hepatocyte growth factor activator inhibitor type 1 (HAI-1) suppresses tumor growth and metastasis of pancreatic adenocarcinoma cells

    Article • Cancer Research, February 2013, American Association for Cancer Research (AACR)

    Dr HIROAKI KATAOKA, Tsuyoshi Fukushima

  7. Regulation of pericellular proteolysis by hepatocyte growth factor activator inhibitor type 1 (HAI-1) in trophoblast cells

    Article • Human Cell, December 2012, Springer Science + Business Media

    Dr HIROAKI KATAOKA, Tsuyoshi Fukushima

  8. HAI-1 regulates invasiveness of oral squamous cell carcinoma

    Article • The Journal of Pathology, April 2012, Wiley

    Dr HIROAKI KATAOKA, Tsuyoshi Fukushima

  9. Antitumor effect of dehydroxymethylepoxyquinomicin, a small molecule inhibitor of nuclear factor- B, on glioblastoma

    Article • Neuro-Oncology, October 2011, Oxford University Press (OUP)

    Tsuyoshi Fukushima

  10. Membrane-Bound Serine Protease Inhibitor HAI-1 Is Required for Maintenance of Intestinal Epithelial Integrity

    Article • American Journal Of Pathology, October 2011, Elsevier

    Tsuyoshi Fukushima

  11. Roles of Insulin-Like Growth Factor Binding Protein-2 in glioblastoma

    Article • September 2011, IntechOpen

    Tsuyoshi Fukushima

  12. Oligodendroglial ganglioglioma

    Article • Brain Tumor Pathology, July 2011, Springer Science + Business Media

    Tsuyoshi Fukushima

  13. Suppressive roles of HAI-1 for pulmonary metastasis

    Article • Cancer Science, December 2010, Wiley

    Dr HIROAKI KATAOKA, Tsuyoshi Fukushima

  14. Hepatocyte growth factor activator is a serum activator of single-chain precursor macrophage-stimulating protein

    Article • FEBS Journal, June 2009, Wiley

    Dr HIROAKI KATAOKA, Tsuyoshi Fukushima

  15. Tissue injury alters the site of expression of hepatocyte growth factor activator inhibitor type 1 in bronchial epithelial cells

    Article • Human Cell, February 2009, Springer Science + Business Media

    Dr HIROAKI KATAOKA, Tsuyoshi Fukushima

  16. Hepatocyte Growth Factor Activator Inhibitor Type 1 Regulates Epithelial to Mesenchymal Transition through Membrane-Bound Serine Proteinases

    Article • Cancer Research, February 2009, American Association for Cancer Research (AACR)

    Tsuyoshi Fukushima

  17. Dickkopf-1 is overexpressed in human pancreatic ductal adenocarcinoma cells and is involved in invasive growth

    Article • International Journal of Cancer, January 2009, Wiley

    Dr HIROAKI KATAOKA, Tsuyoshi Fukushima

  18. Defect of Hepatocyte Growth Factor Activator Inhibitor Type 1/Serine Protease Inhibitor, Kunitz Type 1 (Hai-1/Spint1) Leads to Ichthyosis-Like Condition and Abnormal Hair Development in Mice

    Article • American Journal Of Pathology, November 2008, Elsevier

    Tsuyoshi Fukushima

  19. Establishment and characterization of a new human glioblastoma cells line, NYGM

    Article • Human Cell, October 2008, Springer Science + Business Media

    Dr HIROAKI KATAOKA, Tsuyoshi Fukushima

  20. Expression of hepatocyte growth factor activator inhibitor type 1 on the epithelial cell surface is regulated by hypoxic and oxidative stresses

    Article • Virchows Archiv, September 2008, Springer Science + Business Media

    Dr HIROAKI KATAOKA, Tsuyoshi Fukushima

  21. Intraneural Synovial Sarcoma Originating From the Median Nerve

    Article • Neurologia medico-chirurgica, January 2008, Japan Neurosurgical Society

    Tsuyoshi Fukushima

  22. Silencing of Insulin-like Growth Factor-binding Protein-2 in Human Glioblastoma Cells Reduces Both Invasiveness and Expression of Progression-associated Gene CD24

    Article • Journal of Biological Chemistry, April 2007, American Society for Biochemistry & Molecular Biology (ASBMB)

    Tsuyoshi Fukushima

  23. Clinical relevance of hepsin and hepatocyte growth factor activator inhibitor type 2 expression in renal cell carcinoma

    Article • Cancer Science, April 2007, Wiley

    Dr HIROAKI KATAOKA, Tsuyoshi Fukushima

  24. Role of hepatocyte growth factor activator (HGF activator) in invasive growth of human glioblastoma cells in vivo

    Article • International Journal of Cancer, August 2005, Wiley

    Dr HIROAKI KATAOKA, Tsuyoshi Fukushima

  25. Regeneration of injured intestinal mucosa is impaired in hepatocyte growth factor activator-deficient mice

    Article • Gastroenterology, November 2004, Elsevier

    Tsuyoshi Fukushima